Laparoscopic ovarian transposition before pelvic radiation in rectal cancer patient: safety and feasibility

Table 1 Literature review of cervical and anorectal cancer

Reference	Number	Treatment	Proportion of patients with preserved ovarian function	Follow-up (Months)
Leonard A Farber [3]	1	Radiotherapy + LOT+LAR	100%	13
Hodel et al. [7]	9	RH+LOT±XRT	78%	Ns
Husseinzadeh et al. [8]	22	RH+LOT	100%	Ns
	14	LOT+XRT	67%
	4	RH+LOT+XRT	50%
Chambers et al. [9]	54	RH	96%	54(median)
Chambers et al. [9]	25	RH+LOT	96%	36(median)
Chambers et al. [10]	14	RH+LOT+ Radiotherapy	71%	35(median)
Feeney et al. [11]	58	RH+BSO±XRT	0%	24(mean)
	104	RH+LOT	97%
	28	RH+LOT+XRT	50%
Covens et al. [12]	3	PLND+LOT+XRT	66%	25-32
Van Eijkeren et al. [13]	36	RH+LOT	95%	36-48
Van Eijkeren et al. [13]	18	RH+LOT+XRT	72%	36-48
Morice et al. [14]	11	RH+LOT	100%	31(median)
	59	RH+LOT+Brachy	90%
	35	RH+LOT+XRT+Brachy	60%
Yamamoto et al. [15]	30	RH+LOT	97/89%	At 12 v.s. At 60
Yamamoto et al. [15]	26	RH+LOT+XRT	65/39%	At 12 v.s. At 60
Buekers et al. [16]	17	Radiotherapy + LOT ±RH	41%	At 12
Treissman MJ et al. [17]	1	Radiotherapy +LOT	50%	8

RH radical hysterectomy, LOT lateral ovarian transposition, XRT external beam radiotherapy, BSO bilateral salpingo-oophorectomy, PLND pelvic lymph node dissection only, Brachy brachytherapy, Ns not stated.

ISSN: 1750-1164